Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The new compound may be a safer alternative to finasteride for prostate protection.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

5α-Reductase inhibitors can negatively impact sexual function.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.